Istradefylline to Treat Patients with Parkinson’s Disease Experiencing “off” Episodes: A Comprehensive Review

Istradefylline to Treat Patients with Parkinson’s Disease Experiencing “off” Episodes: A Comprehensive Review

Parkinson’s disease (PD) is a common neurodegenerative disorder that leads to significant morbidity and disability. PD is caused by a loss of dopaminergic, cholinergic, serotonergic, and noradrenergic neurons in the central nervous system (CNS), and peripherally; the syndromic parkinsonism symptoms...

Full description

Bibliographic Details
Main Authors: Amnon A. Berger, Ariel Winnick, Alexandra Welschmeyer, Alicia Kaneb, Kevin Berardino, Elyse M. Cornett, Alan D. Kaye, Omar Viswanath, Ivan Urits
Format: Article
Language:English
Published: MDPI AG 2020-12-01
Series:Neurology International
Subjects:
parkinsonism
levodopa
carbidopa
neurodegenerative
catechol-o-methyl transferase (COMT)
Online Access:https://www.mdpi.com/2035-8377/12/3/17

Internet

https://www.mdpi.com/2035-8377/12/3/17

Similar Items